Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Finasteride improves hair growth in men with androgenetic alopecia.

A new liposomal formulation improves drug delivery and hair growth for treating hair loss without causing skin irritation.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

The new formulation improves dutasteride's absorption when taken orally.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Follistatin helps hair growth and cycling, while activin prevents it.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.

Nanocarriers in gel may reduce side effects of oral hair loss treatments.

Finasteride helps reduce blood vessel growth in diabetic rat kidneys.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

The method produces finasteride with a 92% yield.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Gefitinib can cause scalp skin issues and permanent hair loss.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.